MBRC-201 / MBrace Therap - LARVOL DELTA

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors (clinicaltrials.gov) - P1/2 | N=150 | Recruiting | Sponsor: MBrace Therapeutics | Not yet recruiting ➔ Recruiting

Enrollment open • Breast Cancer • Castration-Resistant Prostate Cancer • Colorectal Cancer • Estrogen Receptor Positive Breast Cancer • Genito-urinary Cancer • Hormone Receptor Positive Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Prostate Cancer • Solid Tumor

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors (clinicaltrials.gov) - P1/2 | N=150 | Not yet recruiting | Sponsor: MBrace Therapeutics

New P1/2 trial • Breast Cancer • Castration-Resistant Prostate Cancer • Colorectal Cancer • Estrogen Receptor Positive Breast Cancer • Genito-urinary Cancer • Hormone Receptor Positive Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Prostate Cancer • Solid Tumor